Skip to main content

Practice Tips

  • Florida's drug price transparency law takes effect

    Pharmacists in Florida can now share cost information with patients, thanks to a new law that took effect July 1.
  • PQS’ EQuIPP now represents 3-in-4 Medicare patients

    As it surpasses this milestone, Pharmacy Quality Solutions said its EQuIPP platform would soon feature more performance measures, including expanded measure sets aimed at adherence for such categories as asthma inhalers, antidepressants and antipsychotics.
  • Liveli’s supplements look to support brain health

    A new nootropic supplement system has hit the market to help protect neurons from damage and strengthen neuroplasticity to allow for greater concentration, memory, and brain capacity.
  • Study: Physicians want EHRs overhaul

    American physicians want substantial improvements in the way electronic health records work, according to new research by Stanford Medicine, conducted by The Harris Poll.
  • Addressing barriers to improve medication adherence

    One of the most important parts of a pharmacist’s job — ensuring their patients properly take the medications they dispense — also is one of the most difficult to accomplish. The first step toward improving adherence is to understand what causes nonadherence, said Cindy Pigg, vice president of Managed Care and Business Development at Cardinal Health.
  • Generation Rx fosters community response to opioid crisis

    As expert healthcare providers in their communities, independent pharmacists are part of the front lines of care to help combat the opioid crisis. Through its Generation Rx program, created in partnership with The Ohio State University College of Pharmacy in 2009, the Cardinal Health Foundation partners with pharmacists and their communities in this fight by extending its prevention education reach and providing support for drug take-back initiatives, safe prescribing practices and strengthening community collaborations.
  • AmerisourceBergen’s Lash Group unveils AI-fueled benefit verification

    The SmartPoint-powered technology is an artificial intelligence-powered system that the company said would reduce time-to-therapy and improve care delivery.
  • FDA approves Novartis’ preventive migraine drug Aimovig

    Aimovig, a once-monthly self-injected drug, works by blocking the activity of a molecule involved in migraines called calcitonin gene-related peptide, the FDA said.
X
This ad will auto-close in 10 seconds